Ann Arbor, MI, United States of America

Omer Yilmaz


Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 47(Granted Patents)


Location History:

  • Ann Arbor, MI (US) (2009 - 2019)
  • Cambridge, MA (US) (2021 - 2022)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Omer Yilmaz: Innovator in Cancer Treatment and Regenerative Medicine

Introduction

Omer Yilmaz is a prominent inventor based in Ann Arbor, MI (US), known for his significant contributions to the fields of cancer treatment and regenerative medicine. With a total of 8 patents, Yilmaz has developed innovative methods and compositions aimed at enhancing Wnt signaling pathways, which play a crucial role in cancer biology.

Latest Patents

Yilmaz's latest patents include groundbreaking work on "Compositions and methods for enhancing Wnt signaling for treating cancer." This invention focuses on methods and compositions that enhance Wnt signaling pathway activities in tissues affected by cancer, particularly those with mutations in the APC gene. The compositions are designed to avoid reducing the proliferation or viability of normal healthy cells. Additionally, he has developed pharmaceutical compositions that include GSK-3 inhibitors, such as LY2090314, which are encapsulated within nanoparticles for effective administration. Another notable patent is for "Beta-hydroxybutyrate encapsulated PLGA nanoparticle compositions," which aims to induce intestinal stem cell regeneration and treat radiation-induced intestinal damage.

Career Highlights

Omer Yilmaz has had a distinguished career, working at prestigious institutions such as the Massachusetts Institute of Technology and the University of Michigan. His research has significantly advanced the understanding of cancer treatment and regenerative medicine, making him a key figure in these fields.

Collaborations

Yilmaz has collaborated with notable colleagues, including Mark J Kiel and Sean J Morrison, contributing to a rich exchange of ideas and innovations in his research endeavors.

Conclusion

Omer Yilmaz's work exemplifies the intersection of innovation and medical science, particularly in the treatment of cancer and regenerative therapies. His patents reflect a commitment to improving patient outcomes through advanced research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…